Arrowhead Pharmaceuticals (ARWR) Financials

$85.11

$-1.23 (-1.42%)

As on 08-Sep-2026 16:14EDT

Market cap

$12,162 Mln

Revenue (TTM)

$670 Mln

P/E Ratio

--

P/B Ratio

26.2

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
Operating Revenue	669.50	829.45	3.55	240.74	243.23	138.29
Cost of Revenue	19.14	23.93	18.60	12.49	10.42	--
Gross Profit	669.50	829.45	-15.04	228.24	243.23	138.29
Operating Expenses	895.93	731.10	586.04	433.24	421.74	287.32
Operating Profit (EBIT)	-226.44	98.35	-601.08	-205.00	-178.51	-149.04
Other Income	--	--	--	--	0.77	2.07
Profit before Tax	-252.08	51.53	-612.46	-206.49	-172.71	-140.85
Provision for Tax	20.05	21.42	-2.77	2.78	3.79	0.00
Profit after Tax (Net Income)	-319.95	-1.63	-599.49	-205.28	-176.49	-140.85
Minority Interest	-47.83	-31.75	10.20	4.00	-0.43	--
Consolidated Profit	--	--	--	-205.28	-176.06	-140.85

Liabilities ($ Mln)	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
Shareholder's Funds	465.53	466.05	185.44	271.34	398.52	408.82
Minority Interest	-47.83	--	--	--	19.82	--
Non-Current Liabilities	1,362.63	686.39	845.57	372.93	134.75	154.79
Current Liabilities	283.35	195.49	103.17	105.46	138.85	146.54
Total Liabilities	2,395.36	1,385.30	1,139.80	765.55	691.94	710.15

Assets ($ Mln)	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
Non-Current Assets	440.60	434.66	444.33	346.03	286.64	325.55
Current Assets	1,671.41	950.64	695.47	419.52	405.30	384.60
Total Assets	2,395.36	1,385.30	1,139.80	765.55	691.94	710.15
Total Debt*	864.07	366.28	851.91	383.50	81.58	25.55
Net Current Assets	1,388.07	755.15	592.30	110.03	302.30	238.06

Cashflow ($ Mln)	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
Cash From Operating Activities	--	179.55	-462.85	-153.89	-136.13	171.31
Cash Flow from Investing Activities	--	-129.29	-420.07	-96.16	-5.42	-141.68
Cash from Financing Activities	--	74.01	870.52	253.05	65.19	11.31
Net Cash Inflow / Outflow	--	--	--	--	-76.36	40.85

Financials Ratios	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
Adjusted EPS ($)	-2.24	-0.01	-4.91	-1.91	-1.67	-1.35
Cash EPS ($)	--	0.16	-4.76	-1.80	-1.57	-1.27
Adjusted Book Value ($)	--	3.43	1.52	2.53	3.77	3.91
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	1.32	-3.79	-1.43	-1.29	1.64
Free Cash Flow per Share ($)	--	1.16	-4.95	-3.08	-1.79	1.41

Profitability Ratios	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
ROCE (%)	--	-0.17	-70.85	-36.17	-38.60	-30.71
ROE (%)	-71.14	-0.50	-262.48	-61.29	-43.72	-32.36
ROA (%)	-16.12	-0.13	-62.93	-28.17	-25.18	-22.85
EBIT Margin (%)	-0.77	16.99	-16,336.47	-78.16	-73.39	-101.85
Net Margin (%)	-47.79	-0.20	-16,882.37	-85.27	-72.33	-100.35
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
Revenue Growth (%)	12.22	232.58	-0.99	-0.01	0.76	0.57
EBIT Growth (%)	93.17	124.29	-208.30	-5.41	-26.74	-51.19
Net Profit Growth (%)	-167.51	99.73	-192.04	-16.31	-25.31	-66.58
EPS Growth (%)	-73.87	1.00	-1.57	-0.15	-0.24	-0.64
Book Value Growth (%)	-13.57	--	--	--	--	--

Valuation Ratios	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
Price / Earnings	--	-2,869.63	-3.94	-14.05	-19.80	-46.33
Price / Book Value	26.25	10.04	12.74	10.63	8.77	15.96
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	27.85	25.04	-4.51	-16.30	-19.04	-46.64
Close Price ($)	81.51	34.49	19.37	26.87	33.05	62.43
High Price ($)	84.55	34.61	39.83	42.48	84.83	93.66
Low Price ($)	14.30	9.57	19.07	23.09	26.81	42.44
Market Cap ($ Cr)	12,161.60	--	--	--	--	--

Solvency Ratios	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
Debt to Equity	1.77	0.79	4.59	1.41	0.20	0.06
Short term debt to equity ratio	0.09	0.10	0.03	0.04	0.01	0.01
Current Ratio	5.90	4.86	6.74	3.98	2.92	2.62
Quick Ratio	5.90	--	--	--	3.07	2.59
Interest Coverage	-1.72	1.58	-17.93	-10.27	-35.47	-23.01

Operating Efficiency Ratios	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
Debtors to sales (%)	1.28	0.82	--	--	0.58	7.42
Asset Turnover	0.34	0.66	0.00	0.33	0.35	0.22
Receivable days	--	1.50	--	1.07	8.76	14.66
Inventory Days	--	--	--	-631.91	-302.34	--
Payable days	--	221.81	464.09	566.22	215.99	--
Cash Conversion Cycle	--	--	--	-1,197.07	-509.57	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.